Seattle Genetics, Inc. today summarized ADCETRIS data in relapsed Hodgkin lymphoma and other CD30-positive malignancies from multiple presentations at the 54th American Society of Hematology Annual Meeting and Exposition being held December 8-11, 2012 in Atlanta, GA.
